Fig. 3From: Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomesTotal daily insulin requirements measured in units/kg during pregnancy (second and third trimester) in women with GDM with myoinositol treated vs. untreated ones, with the further addition of insulin therapy. **p <0.01; ***p <0.001. NS= not significantBack to article page